Figure 1.

PARP1 and PARP2 overexpression is associated with poor survival and advanced stage in NB patients (A and B) Kaplan‐Meier analysis using published array data (dataset 1) from 498 patients and box plots showing the log2‐transformed expression profiles divided by INSS stage categories. (C and D) Kaplan‐Meier analysis using published array data from 402 patients and box plots showing the log2‐transformed expression profiles divided by INSS stage categories considering only non‐MYCN amplified cases